U.S. flag

An official website of the United States government

NM_004817.4(TJP2):c.2040G>A (p.Gly680=) AND not specified

Germline classification:
Benign (2 submissions)
Last evaluated:
May 7, 2012
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000037072.10

Allele description [Variation Report for NM_004817.4(TJP2):c.2040G>A (p.Gly680=)]

NM_004817.4(TJP2):c.2040G>A (p.Gly680=)

Gene:
TJP2:tight junction protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q21.11
Genomic location:
Preferred name:
NM_004817.4(TJP2):c.2040G>A (p.Gly680=)
HGVS:
  • NC_000009.12:g.69236997G>A
  • NG_016342.2:g.141091G>A
  • NM_001170414.2:c.1971G>A
  • NM_001170415.1:c.2052G>A
  • NM_001170416.2:c.2133G>A
  • NM_001369870.1:c.1965G>A
  • NM_001369871.1:c.1971G>A
  • NM_001369872.1:c.2040G>A
  • NM_001369873.1:c.2040G>A
  • NM_001369874.1:c.2052G>A
  • NM_001369875.1:c.2052G>A
  • NM_004817.4:c.2040G>AMANE SELECT
  • NM_201629.3:c.2040G>A
  • NP_001163885.1:p.Gly657=
  • NP_001163886.1:p.Gly684=
  • NP_001163887.1:p.Gly711=
  • NP_001356799.1:p.Gly655=
  • NP_001356800.1:p.Gly657=
  • NP_001356801.1:p.Gly680=
  • NP_001356802.1:p.Gly680=
  • NP_001356803.1:p.Gly684=
  • NP_001356804.1:p.Gly684=
  • NP_004808.2:p.Gly680=
  • NP_963923.1:p.Gly680=
  • LRG_1201t1:c.2040G>A
  • LRG_1201:g.141091G>A
  • LRG_1201p1:p.Gly680=
  • NC_000009.11:g.71851913G>A
  • NG_016342.1:g.120690G>A
  • NM_001170414.1:c.1971G>A
  • NM_004817.3:c.2040G>A
  • c.1971G>A
  • p.Gly657Gly
Links:
dbSNP: rs111723895
NCBI 1000 Genomes Browser:
rs111723895
Molecular consequence:
  • NM_001170414.2:c.1971G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001170415.1:c.2052G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001170416.2:c.2133G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369870.1:c.1965G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369871.1:c.1971G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369872.1:c.2040G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369873.1:c.2040G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369874.1:c.2052G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001369875.1:c.2052G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_004817.4:c.2040G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_201629.3:c.2040G>A - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
4

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000060728Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(May 7, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000310671PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benigngermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided44not providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000060728.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testing PubMed (1)

Description

"Gly657Gly in Exon 15 of TJP2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 1.0% (39/3738) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs111723895)."

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided4not provided4not provided

From PreventionGenetics, part of Exact Sciences, SCV000310671.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 10, 2024